Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17630444 | 0.94 | — | — | |
| Potassium Ion SCHEMBL11576202 | 0.94 | — | — | |
| SCHEMBL1898317 | 0.94 | — | — | |
| SCHEMBL17631227 | 0.94 | — | — | |
| SCHEMBL9500567 | 0.78 | TSHR (0.44) | CA1TSHRTDP1 | |
| Phosphonic Acid SCHEMBL31612472 | 0.78 | CA1 (0.35) | CA1LMNA | |
| SCHEMBL29035583 | 0.77 | CA1 (0.52) | CA1CA2TSHRCYP3A4NFKB1 | |
| SCHEMBL9838014 | 0.72 | — | — | |
| Potassium Ion SCHEMBL19745460 | 0.72 | — | — | |
| SCHEMBL2322447 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8389620-B2 | Blend of unsaturated acid and conjugated unsaturated hydrocarbon polymer, crosslinking agent and cationic polymer | FOUR ROAD RESEARCH LTD. (JP) | 2013-03-05 | — | — | US | disclosed |
| US-20080227913-A1 | LATEX COMPOSITION COMPRISING A CROSS-LINKING AGENT AND MOLDED PRODUCT THEREOF | FOUR ROAD RESEARCH LTD. (JP) | 2008-09-18 | — | — | US | disclosed |
| US-20080207809-A1 | DIP FORMING LATEX COMPOSITION CONTAINING CROSSLINKING AGENT AND DIP FORMED ARTICLE OBTAINED THEREFROM | FOUR ROAD RESEARCH LTD. (JP) | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227913-A1 | LATEX COMPOSITION COMPRISING A CROSS-LINKING AGENT AND MOLDED PRODUCT THEREOF | CAD, JMJD6, CARM1 | CA1 618/4885CA2 1742/4885TSHR 4278/4885 |
| US-20080207809-A1 | DIP FORMING LATEX COMPOSITION CONTAINING CROSSLINKING AGENT AND DIP FORMED ARTICLE OBTAINED THEREFROM | CARM1, CAD, PICALM | CA1 496/4885CA2 1449/4885TSHR 4431/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.